How to Source Lumacaftor + Ivacaftor tablets for Pharmaceutical Formulation
Lumacaftor + Ivacaftor tablets (Tablets, 200 mg lumacaftor + 125 mg ivacaftor) is classified under Orphan Drugs. It is therapeutically aligned with reference brands such as Orkambi®(US & EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Lumacaftor + Ivacaftor tablets for formulation, R&D, or bulk manufacturing.
Product Overview:
Lumacaftor + Ivacaftor tablets treat cystic fibrosis by combining a CFTR corrector (lumacaftor) that improves protein folding and trafficking with a potentiator (ivacaftor) that enhances CFTR channel activity. Benefits include increased lung function, reduced symptoms, improved quality of life, and decreased hospitalization rates in eligible CF patients.
Lumacaftor + Ivacaftor tablets, marketed as Orkambi®, are approved by the FDA and EMA for cystic fib...
Lumacaftor + Ivacaftor tablets API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Lumacaftor + Ivacaftor tablets must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Lumacaftor + Ivacaftor tablets is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Lumacaftor + Ivacaftor tablets is more than procurement—it’s a strategic partnership. With its tablets form and 200 mg lumacaftor + 125 mg ivacaftor specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Lumacaftor + Ivacaftor tablets.
Request a Quote
Frequently Asked Questions For Sourcing of Lumacaftor + Ivacaftor tablets
What is the typical lead time for Lumacaftor + Ivacaftor tablets?
Lead times range from 4–6 weeks depending on supplier and region.
Is Lumacaftor + Ivacaftor tablets available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Lumacaftor + Ivacaftor tablets require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Lumacaftor + Ivacaftor tablets?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Lumacaftor + Ivacaftor tablets?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Lumacaftor + Ivacaftor tablets?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Lumacaftor + Ivacaftor tablets suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Lumacaftor + Ivacaftor tablets be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.